HealthCap invests in Neobiomics to support continued growth in neonatal care Stockholm, Sweden – 20 May 2026. Neobiomics AB, a Swedish life science company focused on improving outcomes for preterm infants through evidence-based nutritional products, today announced an investment led by HealthCap, one of Europe’s… Read More »HealthCap invests in Neobiomics to support continued growth in neonatal care
This January, Neobiomics, represented by Carla Martino, had the pleasure of participating in two major neonatology conferences in Italy: January 11 – Rimini: The Family in the Neonatal Intensive Care Unit: Connection to Overcome Polarization January 16-17 – Rome: 6th Meeting on Fetal-Neonatal Medicine and… Read More »Double Appointment in Italy to Kick Off 2025: Rimini and Rome!
We attended the West Midlands Neonatal Network Mortality Event at the Walsall Manor Hospital in Walsall, UK. The neonatal network includes 15 hospitals and it was a great opportunity to come out and meet current customers, but also speaking to new clinicians. Team Neobiomics was… Read More »West Midlands Perinatal Mortality Event
Emma Zimmermann is the newest edition to Team Neobiomics and will take on the role of Regional Sales Manager UK. Emma brings a wealth of experience as a registered Midwife, over 10 years of clinical experience, along with an extensive background in the medical device… Read More »Emma Zimmermann appointed as Regional Sales Manager
Team Neobiomics is thrilled to announce that NeoMega36® has officially arrived in Slovenia! This marks a significant milestone that we proudly share with our regional distributor, Exceed Orphan. We deeply value our successful partnership and are excited about what we have accomplished together. We eagerly… Read More »First NeoMega36® User in Slovenia